Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis
Abstract Myasthenia gravis (MG) is an autoimmune disease and the most common type of neuromuscular disease. Genes and miRNAs associated with MG have been widely studied; however, the molecular mechanisms of transcription factors (TFs) and the relationship among them remain unclear. A TF–miRNA–gene n...
Guardado en:
Autores principales: | Chunrui Bo, Huixue Zhang, Yuze Cao, Xiaoyu Lu, Cong Zhang, Shuang Li, Xiaotong Kong, Xiaoming Zhang, Ming Bai, Kuo Tian, Aigul Saitgareeva, Gaysina Lyaysan, Jianjian Wang, Shangwei Ning, Lihua Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/218c7dcd85c645919e67f54e28198527 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses
por: Shuang Li, et al.
Publicado: (2021) -
Analysis of serum miRNA profiles of myasthenia gravis patients.
por: Gisela Nogales-Gadea, et al.
Publicado: (2014) -
Profound olfactory dysfunction in myasthenia gravis.
por: Fidias E Leon-Sarmiento, et al.
Publicado: (2012) -
Fetal Surveillance in Pregnancies with Myasthenia Gravis
por: Brîndușa Ana Cimpoca-Raptis, et al.
Publicado: (2021) -
PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
por: Maryam Abbas, et al.
Publicado: (2021)